Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients

Betti Giusti(University of Florence), Gian Franco Gensini(Tecnologie Avanzate (Italy)), Claudia Saracini(University of Florence), Rossella Marcucci(Azienda Ospedaliero-Universitaria Careggi), Rosanna Abbate(University of Florence), Anna Maria Gori(Azienda Ospedaliero-Universitaria Careggi), Serafina Valente(Azienda Ospedaliero-Universitaria Careggi), Rita Paniccia(Azienda Ospedaliero-Universitaria Careggi), D Antoniucci(Azienda Ospedaliero-Universitaria Careggi), Ilaria Sestini(University of Florence)
Pharmacogenetics and Genomics
December 1, 2007
Cited by 228


Related Papers